| Financial Year |
March 31 2023 |
| Monetary Funds |
1,187,448,712.69 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
2,233,777.72 |
| Accounts Receivable |
85,900,166.70 |
| Advances to Suppliers |
2,531,325.34 |
| Other Receivables |
275,668.10 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
88,479,699.92 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
478,507.36 |
| Total Current Assets |
1,395,567,276.87 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
15,729,832.76 |
| Investment Properties |
-- |
| Fixed Assetes |
435,669,605.81 |
| Under-construction Projects |
27,566,034.76 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
73,999,231.22 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
2,931,233.99 |
| Deferred Income Tax Assets |
7,911,466.86 |
| Other Non-Current Assets |
10,366,697.20 |
| Sub-Total of Non-Current Assets |
622,383,746.30 |
| Total Assets |
2,017,951,023.17 |
| Short-Term Loans |
24,623,623.25 |
| Trading Financial liabilities |
-- |
| Notes Payable |
11,030,048.04 |
| Accounts Payable |
57,801,156.39 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
6,150,261.19 |
| Taxes Payable |
5,099,250.56 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
22,958,307.75 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
28,956.56 |
| Other Current Liabilities |
351.82 |
| Sub-Total of Current Liabilities |
130,389,339.99 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,018,752.74 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
43,681,723.30 |
| Total Liabilities |
174,071,063.29 |
| Paid-In Capital(Or Share Stock) |
293,479,151.00 |
| Capital Surplus |
980,554,748.73 |
| Surplus Reserve |
64,688,443.48 |
| LESS:Treasury Stock |
20,448,911.04 |
| Undistributed Profits |
513,759,191.53 |
| Minority Stockholder's Interest |
11,847,336.18 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,832,032,623.70 |
| Owner's Equity（Stockholder's Equity） |
1,843,879,959.88 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,017,951,023.17 |
